Management of Enlarged Prostate and Elevated PSA

Initial Evaluation

The American Urological Association recommends obtaining a complete PSA history to evaluate the pattern and velocity of PSA increase, as PSA velocity changes ≥1.0 ng/ml/year warrant immediate investigation, even if absolute PSA is within normal range 1
A digital rectal examination (DRE) should be performed to assess prostate size, consistency, and presence of nodules or asymmetry that might suggest malignancy, as recommended by the European Association of Urology 2
Review of the patient's medical history, including family history of prostate cancer, is crucial, as it lowers the threshold for biopsy, according to the National Comprehensive Cancer Network 3
Transrectal ultrasound (TRUS) can be used to assess prostate size, shape, and configuration, which may guide treatment options, as suggested by the American Urological Association 4

Prostate biopsy is indicated due to elevated PSA levels, as approximately 1 in 3 men with elevated PSA have prostate cancer, according to the National Comprehensive Cancer Network 5
The biopsy should be performed under transrectal ultrasound guidance with a minimum of 8-12 core samples, as recommended by the European Association of Urology 2
If PSA is >10 ng/ml, the probability of prostate cancer exceeds 50%, making biopsy particularly important, according to the European Association of Urology 6
Measuring free PSA percentage can further assess cancer risk if PSA is in the 4-10 ng/ml range, as suggested by the National Comprehensive Cancer Network 7

Staging should include full blood count, alkaline phosphatase, creatinine, and serum total PSA, as recommended by the European Association of Urology 7
Bone scintigraphy is recommended if PSA >15 ng/ml or if Gleason score is >4+3, according to the European Association of Urology 2
Treatment options should be discussed based on cancer stage, grade, and patient's overall health, including radical prostatectomy, radiation therapy, or active surveillance, as suggested by the European Association of Urology 2

The reason for the suprapubic catheter placement should be evaluated and determined if it can be removed following treatment, as recommended by the American Urological Association 4
Surgical intervention (TURP or other minimally invasive procedures) should be considered if medical therapy fails to allow catheter removal, according to the American Urological Association 4

PSA levels should be monitored every 3-6 months, with special attention to PSA velocity, as recommended by the National Comprehensive Cancer Network 1
For patients on active surveillance, regular PSA testing and periodic repeat biopsies are necessary, according to the European Association of Urology 2
For patients who undergo surgical intervention, follow-up should include assessment of urinary symptoms, flow rate, and post-void residual volume, as suggested by the American Urological Association 4

Elevated PSA may result from various causes, including prostate cancer, BPH, and prostatitis, and false-positive PSA elevations are common, with approximately 2 of 3 men with elevated PSA not having prostate cancer on biopsy, according to the National Comprehensive Cancer Network 5
Age and comorbidities should be considered when determining the aggressiveness of evaluation and treatment, as men older than 75 years may have little to gain from extensive PSA workup, as suggested by the National Comprehensive Cancer Network 5